Literature DB >> 8059785

Gastrointestinal effects of sorbitol as an additive in liquid medications.

K R Johnston1, L A Govel, M H Andritz.   

Abstract

Certain sugar alcohols, notably sorbitol, are widely used as a vehicle for drugs in liquid oral dosage forms. Gastrointestinal side effects due to osmotically active excipients have been described, but remain an underappreciated cause of diarrhea. Quantitating amounts of sorbitol is difficult due to a lack of compendial listings of such information. A computer search of Physicians' Desk Reference monographs was conducted to identify products that listed or potentially contained sorbitol as an inert ingredient. Standard form letters and telephone calls were used to collect information on the sorbitol content of products identified. Data were compiled for 142 products, and each value was converted to mg/mL as crystalline sorbitol. Some difficulty occurred obtaining requested information from some manufacturers in their effort to maintain product formulation confidentiality. Pharmaceutical manufacturers should recognize that technically inert ingredients are not necessarily pharmacologically inactive. Manufacturers should therefore comply with requests for, and more openly publish, quantitative information regarding such ingredients, to facilitate the assessment and treatment of patient symptoms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8059785     DOI: 10.1016/0002-9343(94)90029-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Severe weight loss caused by chewing gum.

Authors:  Juergen Bauditz; Kristina Norman; Henrik Biering; Herbert Lochs; Matthias Pirlich
Journal:  BMJ       Date:  2008-01-12

2.  Presence of Fermentable Oligo-, Di-, Monosaccharides, and Polyols (FODMAPs) in commonly eaten foods: extension of a database to indicate dietary FODMAP content and calculation of intake in the general population from food diary data.

Authors:  Therese Liljebo; Stine Störsrud; Anna Andreasson
Journal:  BMC Nutr       Date:  2020-09-18

Review 3.  Fructose-sorbitol malabsorption.

Authors:  Fernando Fernández-Bañares; Maria Esteve; Josep M Viver
Journal:  Curr Gastroenterol Rep       Date:  2009-10

4.  Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.

Authors:  Hudson C Polonini; Sharlene L Silva; Thalyta R de Almeida; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-03-24

5.  Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.

Authors:  Hudson C Polonini; Sharlene L Silva; Shirley Loures; Rachel Almy; Antoine Balland; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.